p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines

Prog Med Chem. 2001:38:1-60. doi: 10.1016/s0079-6468(08)70091-2.
No abstract available

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use
  • Apoptosis / physiology
  • Arthritis / drug therapy
  • Arthritis / enzymology
  • Bone and Bones / enzymology
  • Cartilage / enzymology
  • Clinical Trials, Phase I as Topic
  • Cytochrome P-450 Enzyme Inhibitors
  • Cytokines / antagonists & inhibitors*
  • Enzyme Activation
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Imidazoles / therapeutic use
  • Lung / enzymology
  • Lung Diseases / drug therapy
  • Lung Diseases / enzymology
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • Mitogen-Activated Protein Kinases / chemistry
  • Mitogen-Activated Protein Kinases / genetics
  • Models, Animal
  • Molecular Sequence Data
  • Myocardial Reperfusion Injury / drug therapy
  • Myocardial Reperfusion Injury / enzymology
  • Neovascularization, Pathologic
  • Psoriasis / enzymology
  • Pyridines / therapeutic use
  • Sequence Alignment
  • Shock, Septic / drug therapy
  • Shock, Septic / enzymology
  • Stroke / drug therapy
  • Stroke / enzymology
  • Virus Diseases / drug therapy
  • Virus Diseases / enzymology
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Anti-Inflammatory Agents
  • Cytochrome P-450 Enzyme Inhibitors
  • Cytokines
  • Enzyme Inhibitors
  • Imidazoles
  • Pyridines
  • SB 242235
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases